Home › NDC Lookup › RxCUI directory › RxCUI 1251903

Ethacrynic acid 25 MG Oral Tablet — RxCUI 1251903

RxNorm drug concept · Semantic clinical drug
RxCUI 1251903 Semantic clinical drug · SCD ● Current RxNorm concept 10 FDA products 15 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1251903
Official nameEthacrynic acid 25 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped10
Package NDCs mapped15
Reported Medicaid activity (SDUD)192 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ethacrynic Acid: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's a strong diuretic — a water pill — used when milder diuretics aren't cutting it. Most commonly, you'd be prescribed it for fluid buildup (edema) related to congestive heart fa...
  • What is ethacrynic acid actually used for?
  • Take it by mouth after a meal — food helps reduce stomach upset. Your prescriber will tell you whether to take it once a day, twice a day, or on an every-other-day schedule. Start...
  • How should I take my ethacrynic acid tablet?
📖 Read our full Ethacrynic Acid guide →

🕸️ Concept Web — How Ethacrynic acid 25 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ethacrynic acid 25 MG Oral Tablet RxCUI 1251903

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Ethacrynate 62349
    • Ethacrynic acid 4109
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Edecrin 151689
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ethacrynate Oral Tablet 617327
    • Ethacrynic acid Oral Tablet 2647723
    • Ethacrynate Oral Product 1156816
    • Ethacrynate Pill 1156817
    • Ethacrynic acid Oral Product 2659396
    • Ethacrynic acid Pill 2659623
    • Ethacrynate Oral Tablet [Edecrin] 619260
    • Ethacrynic acid Oral Tablet [Edecrin] 2658998
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ethacrynic acid 25 MG SCDC · 1251902
  • Ethacrynate Oral Tablet SCDF · 617327
  • Ethacrynic acid Oral Tablet SCDFP · 2647723
  • Ethacrynate Oral Product SCDG · 1156816
  • Ethacrynate Pill SCDG · 1156817
  • Ethacrynic acid Oral Product SCDGP · 2659396
  • Ethacrynic acid Pill SCDGP · 2659623

Brand-Name Concepts

  • Ethacrynic acid 25 MG Oral Tablet [Edecrin] SBD · 1251905
  • Ethacrynic acid 25 MG [Edecrin] SBDC · 1251904
  • Ethacrynate Oral Tablet [Edecrin] SBDF · 619260
  • Ethacrynic acid Oral Tablet [Edecrin] SBDFP · 2658998
  • Edecrin Oral Product SBDG · 1173193
  • Edecrin Pill SBDG · 1173194
  • Edecrin BN · 151689

📦 FDA Products & Package NDCs

10 products · 15 package NDCs
15 package NDCs map to RxCUI 1251903 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00832-1690-11 100 TABLET in 1 BOTTLE (0832-1690-11) Ethacrynic Acid Upsher-Smith Laboratories, LLC 2020-02-19
00832-1690-30 30 TABLET in 1 BOTTLE (0832-1690-30) Ethacrynic Acid Upsher-Smith Laboratories, LLC 2020-02-19
25010-0215-15 100 TABLET in 1 BOTTLE (25010-215-15) EDECRIN Bausch Health US, LLC 1967-01-10
42799-0405-01 100 TABLET in 1 BOTTLE (42799-405-01) Ethacrynic Acid Edenbridge Pharmaceuticals LLC. 2016-07-01
50228-0334-01 1000 TABLET in 1 BOTTLE (50228-334-01) Ethacrynic Acid ScieGen Pharmaceuticals Inc 2019-08-27
50228-0334-10 100 TABLET in 1 BOTTLE (50228-334-10) Ethacrynic Acid ScieGen Pharmaceuticals Inc 2019-08-27
50228-0334-30 30 TABLET in 1 BOTTLE (50228-334-30) Ethacrynic Acid ScieGen Pharmaceuticals Inc 2019-08-27
52817-0367-10 100 TABLET in 1 BOTTLE (52817-367-10) Ethacrynic acid TRUPHARMA LLC 2019-09-12
52817-0367-90 90 TABLET in 1 BOTTLE (52817-367-90) Ethacrynic acid TRUPHARMA LLC 2019-09-12
60760-0773-30 30 TABLET in 1 BOTTLE, PLASTIC (60760-773-30) Ethacrynic Acid St. Mary's Medical Park Pharmacy 2023-02-09
60760-0773-60 60 TABLET in 1 BOTTLE, PLASTIC (60760-773-60) Ethacrynic Acid St. Mary's Medical Park Pharmacy 2023-02-09
68180-0159-01 100 TABLET in 1 BOTTLE (68180-159-01) Ethacrynic Acid Lupin Pharmaceuticals, Inc. 2020-02-24
68682-0011-10 100 TABLET in 1 BOTTLE (68682-011-10) ethacrynic acid Oceanside Pharmaceuticals 1967-01-10
69238-1126-01 100 TABLET in 1 BOTTLE (69238-1126-1) Ethacrynic Acid Amneal Pharmaceuticals NY LLC 2018-05-14
72162-2257-01 100 TABLET in 1 BOTTLE (72162-2257-1) Ethacrynic Acid Bryant Ranch Prepack 2019-08-27
Observed labelers: ScieGen Pharmaceuticals Inc (3) · St. Mary's Medical Park Pharmacy (2) · TRUPHARMA LLC (2) · Upsher-Smith Laboratories, LLC (2) · Amneal Pharmaceuticals NY LLC (1) · Bausch Health US, LLC (1) · +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.7647
Range $0.7647–$0.7647 · middle 50% $0.7647–$0.7647 · 5 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.